推进结直肠癌的向治疗:利用连接体导向的酶前药疗法进行高度特定的干预
Hend Al-Jaber1,2, Kabir H Biswas1, Layla Al-Mansoori2,3
1College of Health & Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
Frontiers in oncology
|June 13, 2025
概括
带导向酶原药疗法 (LDEPT) 提供了一种有针对性的方法来治疗结直肠癌 (CRC),通过在瘤部位直接激活药物. 这种精确方法旨在减少副作用,提高晚期治疗疗效.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康问题,造成严重的死亡率和发病率.
- 现有的高级CRC治疗方法经常与药物耐药性,毒性和非向效应作斗争.
- 激素导向酶前药疗法 (LDEPT) 提出了一种新的策略,以克服这些治疗挑战.
研究的目的:
- 审查结直肠癌的基导酶前药疗法 (LDEPT) 的基本原则和最近的进展.
- 分析LDEPT在CRC治疗中提高精度和降低毒性方面的潜力.
- 讨论LDEPT在临床应用中的挑战和未来方向.
主要方法:
- 对LDEPT用于结直肠癌的临床前研究和初步临床试验的审查.
- 分析LDEPT的机制,包括联体酶复合体和前药激活.
- 探索优化连接体特异性,复杂稳定性和传递的策略.
主要成果:
- 临床前数据表明,LDEPT在向和治疗结直肠癌模型方面具有有希望的结果.
- 早期的临床试验表明,LDEPT有可能改善治疗结果.
- 确定的挑战包括增强连接体特异性,复杂稳定性,输送和管理免疫反应.
结论:
- 作为结直肠癌的向治疗方法,LDEPT具有显著的潜力,可提高精度和降低毒性.
- 进一步的研究和临床验证对于优化LDEPT组件和传递系统至关重要.
- 与免疫疗法等其他疗法的整合可能为先进的CRC管理提供协同效益.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:30Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K